Tokio Marine Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.92M | Buy |
9,895
+471
| +5% | +$209K | 0.15% | 105 |
|
|
2026
Q1 | $4.21M | Buy |
9,424
+100
| +1% | +$46.6K | 0.15% | 114 |
|
|
2025
Q4 | $4.23M | Buy |
9,324
+368
| +4% | +$159K | 0.15% | 116 |
|
|
2025
Q3 | $3.51M | Buy |
8,956
+215
| +2% | +$89.9K | 0.12% | 132 |
|
|
2025
Q2 | $3.89M | Buy |
8,741
+536
| +7% | +$247K | 0.15% | 125 |
|
|
2025
Q1 | $3.98M | Buy |
8,205
+131
| +2% | +$61K | 0.14% | 140 |
|
|
2024
Q4 | $3.25M | Buy |
8,074
+393
| +5% | +$182K | 0.12% | 153 |
|
|
2024
Q3 | $3.57M | Buy |
7,681
+566
| +8% | +$272K | 0.16% | 103 |
|
|
2024
Q2 | $3.33M | Buy |
7,115
+203
| +3% | +$88.1K | 0.16% | 101 |
|
|
2024
Q1 | $2.89M | Buy |
6,912
+386
| +6% | +$163K | 0.15% | 112 |
|
|
2023
Q4 | $2.66M | Buy |
6,526
+564
| +9% | +$208K | 0.15% | 109 |
|
|
2023
Q3 | $2.07M | Buy |
5,962
+739
| +14% | +$258K | 0.13% | 120 |
|
|
2023
Q2 | $1.84M | Buy |
5,223
+250
| +5% | +$84.2K | 0.12% | 121 |
|
|
2023
Q1 | $1.57M | Buy |
4,973
+484
| +11% | +$145K | 0.11% | 138 |
|
|
2022
Q4 | $1.3M | Buy |
4,489
+522
| +13% | +$159K | 0.1% | 157 |
|
|
2022
Q3 | $1.15M | Buy |
3,967
+467
| +13% | +$134K | 0.1% | 149 |
|
|
2022
Q2 | $986K | Buy |
3,500
+260
| +8% | +$69.6K | 0.09% | 162 |
|
|
2022
Q1 | $846K | Buy |
3,240
+548
| +20% | +$130K | 0.07% | 176 |
|
|
2021
Q4 | $591K | Sell |
2,692
-20
| -0.7% | -$3.89K | 0.05% | 229 |
|
|
2021
Q3 | $492K | Buy |
2,712
+373
| +16% | +$72.8K | 0.04% | 238 |
|
|
2021
Q2 | $472K | Buy |
2,339
+381
| +19% | +$79.7K | 0.04% | 227 |
|
|
2021
Q1 | $421K | Buy |
1,958
+211
| +12% | +$46.3K | 0.04% | 215 |
|
|
2020
Q4 | $413K | Buy |
1,747
+162
| +10% | +$37.2K | 0.05% | 195 |
|
|
2020
Q3 | $431K | Buy |
1,585
+196
| +14% | +$54.1K | 0.05% | 166 |
|
|
2020
Q2 | $403K | Buy |
1,389
+180
| +15% | +$48.8K | 0.06% | 155 |
|
|
2020
Q1 | $288K | Buy |
1,209
+238
| +25% | +$54.6K | 0.05% | 162 |
|
|
2019
Q4 | $213K | Buy |
+971
| New | +$197K | 0.03% | 229 |
|
|
2018
Q1 | – | Sell |
-1,569
| Closed | -$235K | – | 305 |
|
|
2017
Q4 | $235K | Sell |
1,569
-563
| -26% | -$83.4K | 0.04% | 280 |
|
|
2017
Q3 | $324K | Sell |
2,132
-792
| -27% | -$119K | 0.05% | 253 |
|
|
2017
Q2 | $377K | Sell |
2,924
-1,040
| -26% | -$125K | 0.05% | 260 |
|
|
2017
Q1 | $433K | Sell |
3,964
-1,628
| -29% | -$143K | 0.06% | 265 |
|
|
2016
Q4 | $412K | Sell |
5,592
-1,602
| -22% | -$130K | 0.05% | 254 |
|
|
2016
Q3 | $627K | Sell |
7,194
-686
| -9% | -$64.8K | 0.07% | 230 |
|
|
2016
Q2 | $678K | Sell |
7,880
-382
| -5% | -$33K | 0.07% | 235 |
|
|
2016
Q1 | $657K | Buy |
8,262
+749
| +10% | +$67.7K | 0.07% | 249 |
|
|
2015
Q4 | $945K | Sell |
7,513
-661
| -8% | -$79.8K | 0.1% | 174 |
|
|
2015
Q3 | $851K | Sell |
8,174
-483
| -6% | -$62.1K | 0.09% | 199 |
|
|
2015
Q2 | $1.07M | Sell |
8,657
-1,290
| -13% | -$163K | 0.11% | 175 |
|
|
2015
Q1 | $1.17M | Sell |
9,947
-1,675
| -14% | -$201K | 0.11% | 180 |
|
|
2014
Q4 | $1.38M | Sell |
11,622
-3,277
| -22% | -$369K | 0.12% | 181 |
|
|
2014
Q3 | $1.67M | Sell |
14,899
-1,695
| -10% | -$161K | 0.12% | 189 |
|
|
2014
Q2 | $1.57M | Hold |
16,594
| – | – | 0.11% | 197 |
|
|
2014
Q1 | $1.17M | Sell |
16,594
-900
| -5% | -$71.3K | 0.08% | 268 |
|
|
2013
Q4 | $1.3M | Sell |
17,494
-357
| -2% | -$24.9K | 0.08% | 245 |
|
|
2013
Q3 | $1.35M | Hold |
17,851
| – | – | 0.09% | 236 |
|
|
2013
Q2 | $1.43M | Buy |
+17,851
| New | +$1.31M | 0.09% | 229 |
|
Other funds holding VRTX
Tokio Marine Asset Management's VRTX Position: Q2 2026 in Review
Tokio Marine Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 5% in Q2 2026, buying an estimated $209K and bringing the position to 9,895 shares worth $4.92M. The position accounts for 0.15% of the portfolio, ranked #105.
Tokio Marine Asset Management first reported a position in VRTX in Q2 2013 and has held it in 46 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Tokio Marine Asset Management held 9,895 shares of Vertex Pharmaceuticals worth $4.92M as of Q2 2026.
- Tokio Marine Asset Management bought 471 Vertex Pharmaceuticals shares in Q2 2026, an estimated $209K.
- Vertex Pharmaceuticals made up 0.15% of Tokio Marine Asset Management's portfolio in Q2 2026, its #105 holding.
- Tokio Marine Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 46 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.